Introduction: Refractory right ventricular failure (RVF) after the implantation of left ventricular
assisted device (LVAD) is induced with increased morbidity and mortality. Case: A 23- year-old man with severe heart failure was hospitalized due to dilated cardiomyopathy
with severe heart failure. Despite intensive care including intra-aortic balloon pumping
and intravenous dobutamine, his cardiac function declined progressively and we decided
to implant a LVAD as a bridge to transplantation. Three months after implantation,
RVF was suspected due to the presence of leg edema and pleural effusion. His echocardiography
showed dysfunction of both ventricles and moderate tricuspid regurgitation. Cardiac
catheterization showed his mean right atrial pressure; 18 mmHg, mean pulmonary arterial
pressure; 31 mmHg, pulmonary vascular resistance (PVR); 2.7 Wood units, cardiac index;
1.6 L/min/m2. Although we started administering dobutamine and milrinone and raising
the pump speed against worsening RVF, his symptoms did not improve. Furthermore, a
PDE5 inhibitor, sildenafil was tried to treat RVF. Although his PVR was not high,
his symptoms improved notably. Conclusions: We report a case in whom the administration of sildenafil for RVF after LVAD implantation
resolved symptoms despite PVR not being high. Potent pulmonary hypertension drugs
may enable treatment of RVF after LVAD even if PVR is normal.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Cardiac FailureAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect